Before my neurologist pointed a single patient toward creatine, she did something most doctors never do.
She ordered the 9 top-selling creatine brands on Amazon.
All with hundreds of five-star reviews.
All claiming high quality and accurate dosing.
She ran every one through independent lab analysis.
The results were worse than she expected.
4 brands were more than 54% underdosed.
Not slightly off.
More than half the active dose stated on the label was simply not there.
3 brands had contamination problems.
Bacterial markers in supplements women were putting in their bodies every single day.
The remaining brands had absorption issues that made the creatine essentially useless even when the dose was technically present.
And not one — not one out of nine — contained Alpha-GPC.
Not one.
"Women are spending money every month on these products," she said.
"Feeling nothing. Concluding creatine doesn't work for them."
"It's not that creatine doesn't work."
"They were never actually getting real creatine."
She spent a full week after that going through clinical-grade suppliers, lab certifications, and formulation data.
She was looking for one specific thing.
A product with clinical-dose creatine monohydrate AND Alpha-GPC together.
Third-party verified.
Made specifically for postmenopausal women.
She found one brand.
She ordered it independently and ran it through her own lab before she recommended it to anyone.
Her results:
5,082mg of active creatine in a labeled 5,000mg dose.
Not underdosed. Over-delivered.
Clean powder. Zero contamination.
Alpha-GPC present and verified at full clinical dose.
"This is the only creatine I recommend to my patients," she said.
"Every woman who comes to me feeling like she's losing herself — this is what I give her."
"It is the only one I have tested that actually delivers what the postmenopausal brain needs."
She wrote the name on a notepad.
Slid it across the desk.
Veluoria.
I ordered it before I got home.